Religare Enterprises
- Market cap
- ₹ 6,984 Cr.
- P/E
- 149x
- P/B
- 2.38x
- 52-week range
- 196.51 – 280
- ROE
- 3%
- ROCE
- 3%
- Dividend yield
- 0%
- Debt / equity
- 0.2
- Sector
- Finance
- Industry
- Investment Company
- Listed on
- NSE, BSE
About
Religare Enterprises Limited is an India-based diversified financial services company. The Company, through its subsidiaries, is primarily engaged in providing financial services, including loans to small and medium enterprises (SMEs), housing finance, health insurance, and retail broking. Its segments include Investment and Financing Activities, Support Services, Broking Related Activities, E-Governance, and Insurance. It offers Affordable Housing Finance and SME Finance. Its subsidiaries include Religare Capital Markets (UK) Limited, Religare Commodities Limited, Care Health Insurance Limited, among others. Care Health Insurance Limited is an insurer offering products in the retail segment of Health Insurance, Top-up Coverage, Personal Accident, Maternity, International Travel Insurance and Critical Illness. Religare Commodities Limited offers broking services in equity, currency and commodities as well as depository participant services.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Investment Company: 66 companies →Religare Enterprises against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)149 against a typical 40.7: pricier than most peers (1st = cheapest).55th of 66
- Sales growth+26.4% against a typical +16.7% from a year earlier.24th of 55
- Profit growth−687.5% against a typical 0% from a year earlier.46th of 50
- Share price, 3 months−14.3% against a typical −10.3%.45th of 66
- Size₹ 6,983.6 Cr. market value against a typical ₹ 171.2 Cr. (1st = largest).9th of 61
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 12 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 12 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 14 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 13 Nov 2025 | Financial Results | To consider and approve the limited reviewed financial results for the period ended September 30, 2025 |
| 12 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 11 Jul 2025 | Fund Raising | To consider Fund Raising |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,584 | 1,511 | 1,856 | 1,710 | 1,952 | 1,668 | 2,042 | 1,861 | 2,077 | 2,056 | 2,467 | 2,353 |
| Expenses | 1,483 | 1,455 | 1,833 | 1,653 | 1,876 | 1,730 | 1,805 | 1,846 | 2,010 | 2,151 | 2,325 | 2,402 |
| Operating Profit | 101 | 56 | 23 | 57 | 76 | −61 | 237 | 15 | 67 | −95 | 143 | −49 |
| OPM % | 6% | 3.7% | 1.2% | 3.3% | 3.9% | −3.7% | 12% | 0.8% | 3.2% | −4.6% | 6% | −2.1% |
| Other Income | 1 | 27 | 249 | 5 | 19 | 2 | 8 | 10 | 12 | 12 | 6 | 5 |
| Interest | 25 | 24 | 18 | 13 | 13 | 5 | 6 | 7 | 10 | 9 | 10 | 15 |
| Depreciation | 18 | 18 | 17 | 16 | 15 | 14 | 17 | 13 | 12 | 11 | 12 | 18 |
| Profit before tax | 59 | 41 | 236 | 33 | 67 | −79 | 222 | 6 | 57 | −103 | 127 | −77 |
| Tax % | 32% | 18% | 23% | 18% | −2% | −20% | 32% | −42% | 20% | −26% | 25% | −39% |
| Net Profit | 40 | 34 | 181 | 27 | 69 | −63 | 151 | 8 | 46 | −77 | 96 | −47 |
| EPS in Rs | 0.78 | 0.59 | 3.8 | 0.55 | 1.55 | −1.3 | 2.98 | 0.31 | 1.17 | −1.36 | 2.47 | −0.77 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 6%
- 5 Years
- 27%
- 3 Years
- 22%
- TTM
- 19%
- 10 Years
- 12%
- 5 Years
- 17%
- 3 Years
- 71%
- TTM
- −58%
- 10 Years
- −1%
- 5 Years
- 11%
- 3 Years
- 1%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 4%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Religare Enterprises | ₹ 214.50 | ₹ 6,984 Cr. | 149x | 2.4x | 3% | — |
| ICICI Prudential Asset Management Company Ltd | ₹ 2,655.00 | ₹ 1,30,928 Cr. | 47.7x | 37.7x | — | 56% |
| HDFC Asset Management Company | ₹ 2,250.00 | ₹ 96,542 Cr. | 39.9x | 12.3x | — | 69.3% |
| Nippon Life India Asset Management | ₹ 922.10 | ₹ 59,010 Cr. | 50.1x | 16.3x | 34.5% | 56.4% |
| Multi Commodity Exchange Of India | ₹ 3,017.00 | ₹ 76,931 Cr. | 52.6x | 16.6x | 37.9% | 57.8% |
| Motilal Oswal Financial Services | ₹ 925.00 | ₹ 55,715 Cr. | 30.8x | 4.5x | 15.6% | 21.2% |
Management
- Pankaj Gupta
- Chief Financial Officer
- Rajesh Sharma
- President - Internal Audit
- Indranil Choudhury
- Group Chief Human Resources Officer
- Babu Rao Priya
- Group General Counsel and Group Chief Compliance Officer
- Arjun Lamba
- Whole Time Director
- Anuj Jain
- Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.